InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,473.17
(
-0.25%
)
US TECH 100
19,251.60
(
-0.04%
)
Dow Jones
39,134.76
(
0.77%
)
Brent Oil
84.94
(
-0.08%
)
Bitcoin
63,865.84
(
-1.47%
)
Post# of 252279
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

apljack

Send PM Follow Ignore
Followers 6
Posts 703
Boards Moderated 0
Alias Born 09/23/2006

apljack

Re: genisi post# 126642

Friday, 09/16/2011 8:21:13 PM

Friday, September 16, 2011 8:21:13 PM

Post# of 252279
Re:Diagnostic Pathology

Hello DT! Didn't know that one could quantify a journal's impact, but it is no surprise to me that you know this.

My take is that the co. had to settle with a low tier journal (after failed submission(s) to more prestigious ones) to get their data published, and the comments thus far (from Peter and JB118) further point out that the test itself is not going to light any fires in terms of revenue.

Thanks for the imput, and hope you are well,

aj
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up